SIGNATURE R & D HOLDINGS LLC has a total of 17 patent applications. Its first patent ever was published in 2004. It filed its patents most often in Republic of Korea, New Zealand and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are BRISTOL-MYERS SQUIBB COMPANY, BRISTOL MYERS SQUIBB COMPANY UNA CORPORACIÓN DEL ESTADO DE DELAWARE and XTL BIOPHARMACEUTICALS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 3 | |
#2 | New Zealand | 3 | |
#3 | United States | 3 | |
#4 | Singapore | 2 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Chandran V Ravi | 12 |
#2 | Chandran V | 2 |
#3 | Ravi Chandran V | 1 |
Publication | Filing date | Title |
---|---|---|
US2006287244A1 | L-Threonine derivatives of high therapeutic index | |
CN101123878A | L-threonine derivatives of high therapeutic index |